No photo of Amit K. Verma

View Scopus Profile

Amit K. Verma, M.B.,B.S.

  • 7343 Citations
  • 51 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 41 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Therapeutic targeting of glutamine metabolism in MDS

Verma, A. K. & Verma, A. K.

National Cancer Institute

4/1/16 → 3/31/21

Project: Research project

    • Cooperative Research Agreements Related to the World Trade Center Health Program (U01)

    Verma, A. K.

    1/1/19 → 6/30/20

    Project: Research project

    Early Detection of Hematologic Malignancies in New York City Firefighters Exposed To World Trade Center Dust After The 9/11 Attacks

    Prezant, D. J., Verma, A. K. & Prezant, D. J.

    National Institutes of Health

    7/1/17 → 6/30/20

    Project: Research project

    • Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes

    Verma, A. K.

    9/1/14 → 5/31/18

    Project: Research project

    The role of Dock4 in normal and aberrant erythropoiesis

    Verma, A. K., Wickrema, A. & Verma, A. K.

    9/26/12 → 6/30/17

    Project: Research project

    Publications

    A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19

    Gonzalez-Lugo, J. D., Bachier-Rodriguez, L., Goldfinger, M., Shastri, A., Sica, R. A., Gritsman, K., Mehta, V., Kabarriti, R., Goel, S., Verma, A., Braunschweig, I., Kornblum, N. & Mantzaris, I., 2020, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journal › Letter

    Open Access

    Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

    Abbasi, A., Peeke, S., Shah, N., Mustafa, J., Khatun, F., Lombardo, A., Abreu, M., Elkind, R., Fehn, K., de Castro, A., Wang, Y., Derman, O., Nelson, R., Uehlinger, J., Gritsman, K., Sica, R. A., Kornblum, N., Mantzaris, I., Shastri, A., Janakiram, M. & 4 others, Goldfinger, M., Verma, A., Braunschweig, I. & Bachier-Rodriguez, L., Jan 3 2020, In : Journal of hematology & oncology. 13, 1, 1 p.

    Research output: Contribution to journal › Letter

    Open Access
    • 1 Scopus citations

    Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes

    Verma, A., Suragani, R. N. V. S., Aluri, S., Shah, N., Bhagat, T. D., Alexander, M. J., Komrokji, R. & Kumar, R., Feb 3 2020, In : Journal of Clinical Investigation. 130, 2, p. 582-589 8 p.

    Research output: Contribution to journal › Review article

    • 2 Scopus citations

    Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

    Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., Gartrell, B. A., Smith, R. V., Ohri, N., Garg, M., Racine, A. D., Kalnicki, S., Perez-Soler, R., Halmos, B. & Verma, A., Jul 1 2020, In : Cancer discovery. 10, 7, p. 935-941 7 p.

    Research output: Contribution to journal › Article

    Open Access

    • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    COVID-19 and Cancer Consortium, Jun 20 2020, In : The Lancet. 395, 10241, p. 1907-1918 12 p.

    Research output: Contribution to journal › Article

    Open Access
    • 9 Scopus citations